CDT Equity Inc. (CDT)
NASDAQ: CDT
· Real-Time Price · USD
1.18
-0.01 (-0.84%)
At close: Sep 05, 2025, 3:59 PM
1.20
1.69%
After-hours: Sep 05, 2025, 04:55 PM EDT
Company Description
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets.
The company was founded by David Joszef Tapolczay and Freda C.
Lewis-Hall in October 2021 is headquartered in Naples, FL.
CDT Equity Inc.

Country | United States |
IPO Date | Mar 28, 2022 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 6 |
CEO | James Bligh |
Contact Details
Address: 4581 Tamiami Trail North Naples, Florida United States | |
Website | https://www.conduitpharma.com |
Stock Details
Ticker Symbol | CDT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000913142 |
CUSIP Number | 20678X106 |
ISIN Number | US20678X3044 |
Employer ID | 36-3601505 |
SIC Code | 3357 |
Key Executives
Name | Position |
---|---|
Dr. Andrew Regan | Founder, Chief Executive Officer & Director |
James Bligh | Interim Chief Financial Officer & Director |
Dr. David Joszef Tapolczay | Head of Strategy & Licensing |
Dr. Joanne M. Holland | Chief Scientific Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Sep 04, 2025 | 4 | Filing |
Aug 27, 2025 | 8-K | Current Report |
Aug 26, 2025 | 4 | Filing |
Aug 26, 2025 | 4 | Filing |
Aug 26, 2025 | 4 | Filing |
Aug 21, 2025 | 4 | Filing |
Aug 18, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Aug 14, 2025 | 10-Q | Quarterly Report |
Aug 14, 2025 | 10-Q/A | [Amend] Quarterly Report |
Aug 14, 2025 | 8-K | Current Report |